Terms: = Germ cell tumor AND CEACAM5, CEA AND Prognosis
89 results:
1. Expression and clinical value of CXCR4 in high grade gastroenteropancreatic neuroendocrine neoplasms.
Pang C; Li Y; Shi M; Fan Z; Gao X; Meng Y; Liu S; Gao C; Su P; Wang X; Zhan H
Front Endocrinol (Lausanne); 2024; 15():1281622. PubMed ID: 38524630
[TBL] [Abstract] [Full Text] [Related]
2. Measuring discrepancies between simple medullary and synchronous medullary/papillary thyroid carcinomas: a comparative cross-sectional study.
Zhang D; Yang M; Frattini F; Cestari A; Li K; Wang H; Chi H; Sui C; Bai K; Lan D; Dionigi G; Sun H
Front Endocrinol (Lausanne); 2023; 14():1301200. PubMed ID: 38317715
[TBL] [Abstract] [Full Text] [Related]
3. POU2F3-Expressing Small cell Lung Carcinoma and Large cell Neuroendocrine Carcinoma Show Morphologic and Phenotypic Overlap.
Jimbo N; Ohbayashi C; Takeda M; Fujii T; Mitsui S; Tsukamoto R; Tanaka Y; Itoh T; Maniwa Y
Am J Surg Pathol; 2024 Jan; 48(1):4-15. PubMed ID: 37904277
[TBL] [Abstract] [Full Text] [Related]
4. Preoperative neck ultrasound combined with pathological data can significantly impact the outcome of medullary thyroid carcinoma.
Deandrea M; Piticchio T; Mormile A; Retta F; Canale G; Caracciolo A; Daniele L; Trimboli P
Endocr J; 2023 Nov; 70(11):1061-1067. PubMed ID: 37690841
[TBL] [Abstract] [Full Text] [Related]
5. [Hereditary medullary thyroid cancer].
Fendrich V; Zahn A
Chirurgie (Heidelb); 2023 May; 94(5):393-399. PubMed ID: 36799965
[TBL] [Abstract] [Full Text] [Related]
6. Diagnostic role and prognostic value of tumor markers in high-grade gastro-enteropancreatic neuroendocrine neoplasms.
Gao C; Fan Z; Yang J; Shi M; Li Y; Zhan H
Pancreatology; 2023 Mar; 23(2):204-212. PubMed ID: 36710224
[TBL] [Abstract] [Full Text] [Related]
7. Other markers of medullary thyroid cancer, not only calcitonin.
Censi S; Manso J; Mian C
Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36651167
[TBL] [Abstract] [Full Text] [Related]
8. A Rare Case of Negative Serum Calcitonin in Metastatic Medullary Thyroid Carcinoma: Diagnosis, Treatment, and Follow-Up Strategy.
Licata L; Di Fidio CA; Vacante M; Basile F; Biondi A; Richiusa P; Gurrera A; Ciuni R
Am J Case Rep; 2022 Sep; 23():e935207. PubMed ID: 36088532
[TBL] [Abstract] [Full Text] [Related]
9. Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis.
Zhang S; Chen J; Zhang R; Xu L; Wang Y; Yuan Z; Hou X; Feng J
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1063-1077. PubMed ID: 35249158
[TBL] [Abstract] [Full Text] [Related]
10. Utilizing the circulating tumor markers in diagnosis and management of medullary thyroid cancer.
Zarkesh M; Arab N; Tavangar SM; Nozhat Z; Fanaei SM; Hedayati M
Pathol Res Pract; 2022 Jan; 229():153694. PubMed ID: 34929598
[TBL] [Abstract] [Full Text] [Related]
11. Serum Biomarker Status with a Distinctive Pattern in prognosis of Gastroenteropancreatic Neuroendocrine Carcinoma.
Zhang J; Cao Y; Zhang P; Zhang X; Li J; Zhou J; Wang X; Peng Z; Sun Y; Li J; Shen L; Lu M
Neuroendocrinology; 2022; 112(8):733-743. PubMed ID: 34592743
[TBL] [Abstract] [Full Text] [Related]
12. A Review of the Significance in Measuring Preoperative and Postoperative Carcinoembryonic Antigen (cea) Values in Patients with Medullary Thyroid Carcinoma (MTC).
Passos I; Stefanidou E; Meditskou-Eythymiadou S; Mironidou-Tzouveleki M; Manaki V; Magra V; Laskou S; Mantalovas S; Pantea S; Kesisoglou I; Sapalidis K
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34208296
[No Abstract] [Full Text] [Related]
13. Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer.
Matrone A; Prete A; Nervo A; Ragni A; Agate L; Molinaro E; Giani C; Valerio L; Minaldi E; Piovesan A; Elisei R
J Endocrinol Invest; 2021 Oct; 44(10):2139-2151. PubMed ID: 33594641
[TBL] [Abstract] [Full Text] [Related]
14. High Ratio of Early Postoperative Calcitonin to Preoperative Calcitonin Could be a Novel Indicator of Poor prognosis in Patients with Biochemical Incomplete Responses in Sporadic Medullary Thyroid Cancer.
Chen L; Sun W; Qian K; Guo K; Sun T; Wu YI; Wang Z
Endocr Pract; 2020 Jul; 26(7):738-747. PubMed ID: 33471642
[TBL] [Abstract] [Full Text] [Related]
15. Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades.
Kotwal A; Erickson D; Geske JR; Hay ID; Castro MR
Thyroid; 2021 Apr; 31(4):616-626. PubMed ID: 33108969
[No Abstract] [Full Text] [Related]
16. Preoperative Differentiation of Benign and Malignant Non-epithelial Ovarian tumors: Clinical Features and tumor Markers.
Gomes TA; Campos EA; Yoshida A; Sarian LO; Andrade LALA; Derchain SF
Rev Bras Ginecol Obstet; 2020 Sep; 42(9):555-561. PubMed ID: 32992358
[TBL] [Abstract] [Full Text] [Related]
17. Gynecologic cancer in pregnancy.
Korenaga TK; Tewari KS
Gynecol Oncol; 2020 Jun; 157(3):799-809. PubMed ID: 32268951
[TBL] [Abstract] [Full Text] [Related]
18. Expression of Prox1 in Medullary Thyroid Carcinoma Is Associated with Chromogranin A and Calcitonin Expression and with Ki67 Proliferative Index, but Not with prognosis.
Saglietti C; La Rosa S; Sykiotis GP; Letovanec I; Bulliard JL; Piana S; Mermod M; Petrova T; Uccella S; Sessa F; Bongiovanni M
Endocr Pathol; 2019 Jun; 30(2):138-145. PubMed ID: 31001799
[TBL] [Abstract] [Full Text] [Related]
19. Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer.
Turkdogan S; Forest VI; Hier MP; Tamilia M; Florea A; Payne RJ
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):55. PubMed ID: 30223887
[TBL] [Abstract] [Full Text] [Related]
20. Rare case of a gallbladder neuroendocrine carcinoma.
Fujii M; Saito H; Shiode J
Clin J Gastroenterol; 2019 Feb; 12(1):38-45. PubMed ID: 30003469
[TBL] [Abstract] [Full Text] [Related]
[Next]
